The story appears on

Page A10

September 30, 2010

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » World

US stem cell study is allowed to continue

A UNITED States appeals court on Tuesday allowed federal funding for human embryonic stem cell research to continue pending a full appeal, lifting an injunction issued last month by a federal judge and handing a victory to the Obama administration.

A three-judge panel of the US Court of Appeals for the District of Columbia Circuit said the Obama administration had "satisfied the standards required for a stay pending appeal" of the injunction originally imposed in August.

Judge Royce Lamberth issued the ban after finding the US National Institutes of Health (NIH) guidelines on the research violated the law because embryos were destroyed in the process and it put other researchers working with adult stem cells at a competitive disadvantage for federal grants.

The Obama administration challenged his ruling and asked the appeals court to put the injunction on hold pending its decision on the merits of the dispute. The appeals court ordered an expedited schedule for arguments.

President Barack Obama has increased federal funding for research involving human embryonic stem cells in the hope that it will lead to cures for more diseases. Opponents argue, usually on religious grounds, that the research is unacceptable because it damages or destroys human embryos.

Human embryonic stem cells come from days-old embryos and can produce any type of cell in the body. Scientists hope to be able to use them to address spinal cord injuries, cancer, diabetes and diseases such as Alzheimer's and Parkinson's.

During a lengthy argument on Monday, government lawyers warned the three-judge panel that dozens of research projects would be ruined if their funding was cut, wasting millions of taxpayer dollars and causing irreparable harm.

Lamberth's injunction came after a challenge by two researchers who work with adult stem cells and opposed work with embryonic stem cells - Dr James Sherley, a biological engineer at Boston Biomedical Research Institute, and Theresa Deisher, research director of Washington-based AVM Biotechnology.



 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend